Focada exclusivamente no desenvolvimento, 
                                        produção e promoção de produtos farmacêuticos especializados

Notice to the Market – Loan prepayment


Grupo Biotoscana announces loan prepayment

Montevideo, Uruguay, December 29, 2017. GBT-Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical company in Latin America, announces to its shareholders and the market in general that, on December 28, 2017, the Company prepaid its loan with Bancolombia, fully liquidating the Company’s outstanding debt with the Colombian financial institution.

The total amount of the prepaid loan settlement was COP 256,000 million, which includes COP 133,000 million paid on October 9, 2017 and the remaining COP 123,000 million paid on December 28, 2017.

The purpose of this transaction is to reduce the Company’s cost of debt and obtain more financial flexibility. Thus, GBT reaffirms its commitment to generate value for its shareholders through the optimization of its capital structure.

GBT – Grupo Biotoscana.
Melissa Angelini
IR Manager
Tel.: +55 11 5090 5927

To access the PDF version, please click here.

Updated on 01/02/2019 at 04:49 pm